{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DSKYF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSKYF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSKYF\",,,,,undefined,":{"symbol":"DSKYF","market":"US","secType":"STK","nameCN":"Daiichi Sankyo Co., Ltd.","latestPrice":26.99,"timestamp":1748462400000,"preClose":24.45,"halted":0,"volume":8636,"delay":15,"floatShares":1876450459,"shares":1916602000,"eps":0.742527,"marketStatus":"Pre-Mkt","change":2.54,"latestTime":"05-28 16:00:00 EDT Delay","open":28.89,"high":29.05,"low":25.35,"amount":231655.47,"amplitude":0.151329,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.742527,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748525400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":26.99,"volumeRatio":0.4614480410192428},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSKYF\",,,,,undefined,":{"symbol":"DSKYF","floatShares":1876450459,"roa":"6.00%","roe":"17.86%","lyrEps":0.692127,"volumeRatio":0.4614480410192428,"shares":1916602000,"dividePrice":0.41418,"high":29.05,"amplitude":0.151329,"preClose":24.45,"low":25.35,"week52Low":20.15,"pbRate":"4.62","psRate":"3.97","week52High":44.64,"institutionHeld":0,"latestPrice":26.99,"eps":0.742527,"divideRate":0.015346,"volume":8636,"delay":15,"ttmEps":0.742527,"open":28.89,"prevYearClose":26.6,"prevWeekClose":28.1,"prevMonthClose":24.16,"prevQuarterClose":22.01,"fiveDayClose":26.31,"twentyDayClose":26.05,"sixtyDayClose":22.7},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DSKYF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSKYF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537540607","title":"Analysts Are Bullish on Top Healthcare Stocks: Daiichi Sankyo Company (DSKYF), Innovent Biologics (IVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537540607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537540607?lang=en_us&edition=fundamental","pubTime":"2025-05-21 16:30","pubTimestamp":1747816218,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Daiichi Sankyo Company (DSKYF – Research Report), In...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-daiichi-sankyo-company-dskyf-innovent-biologics-ivbxf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-daiichi-sankyo-company-dskyf-innovent-biologics-ivbxf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","BK4007","DSKYF","IVBXF","HCSG"],"gpt_icon":0},{"id":"2535520573","title":"Bernstein Sticks to Its Buy Rating for Daiichi Sankyo Company (DSKYF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535520573","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535520573?lang=en_us&edition=fundamental","pubTime":"2025-05-16 16:35","pubTimestamp":1747384532,"startTime":"0","endTime":"0","summary":"Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,40...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-its-buy-rating-for-daiichi-sankyo-company-dskyf-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-its-buy-rating-for-daiichi-sankyo-company-dskyf-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSKYF"],"gpt_icon":0},{"id":"2532272248","title":"TAK or DSNKY: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532272248","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532272248?lang=en_us&edition=fundamental","pubTime":"2025-05-02 23:40","pubTimestamp":1746200408,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co.  and Daiichi Sankyo Co., Ltd. - Sponsored ADR . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.Currently, Takeda Pharmaceutical Co. has a Zacks Rank of #2 , while Daiichi Sankyo Co., Ltd. - Sponsored ADR has a Zacks Rank of #3 . This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that TAK is likely seeing its earnings outlook improve to a greater extent. But this is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tak-dsnky-better-value-stock-154008748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DSNKY","DSKYF","BK4007","TAK"],"gpt_icon":0},{"id":"2529803706","title":"AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803706","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803706?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:05","pubTimestamp":1745237101,"startTime":"0","endTime":"0","summary":"AstraZeneca Plc  on Monday released topline data from the DESTINY-Breast09 Phase 3 trial ofEnhertu either alone or in combination with pertuzumab versus standard of care THP  as a first-line treatment in patients with HER2-positive metastatic breast cancer.High-level results from a planned interim analysis showed Enhertu pertuzumab combination demonstrated a statistically significant and clinically meaningful improvement in progression-free survival  compared to THP.Also Read: European Drug Regulator Approves AstraZeneca’s Two Flagship Cancer Drugs For Breast And Lung Cancer Settings. HER2-positive metastatic breast cancer is an aggressive disease driven by overexpression or amplification of HER2, affecting 15-20% of patients with metastatic breast cancer.While HER2-targeted therapies have improved outcomes, prognosis remains poor, with most patients experiencing disease progression within two years of 1st-line treatment with THP, which has been the standard of care for more than a dec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-daiichi-sankyos-multi-billion-120501820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2462157665.USD","BK4211","LU0889565916.HKD","BK4080","BK4585","BK4007","LU0320765992.SGD","LU2456880835.USD","AZN","LU1829250122.USD","DSKYF","LU0109394709.USD","LU2236285917.USD","BK4588","ADC","BK4097","BK4231","OS","BK4568","BK4195","DSNKY","PFS","LU2417539215.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSKYF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-25","symbol":"DSKYF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-30","symbol":"DSKYF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706590800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"DSKYF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"post","actualEps":null},{"date":"2023-09-28","symbol":"DSKYF","amount":17,"announcedDate":"2023-07-19","type":"dividend","market":"US","newRecordDate":"2023-09-30","defaultRemindTime":1695907800000,"name":"Daiichi Sankyo Co., Ltd.","recordDate":"2023-12-01","payableDate":"2023-09-30","currency":"JPY","dateTimestamp":1695873600000,"payDate":"2023-12-01"},{"market":"US","date":"2023-07-31","symbol":"DSKYF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690776000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSKYF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-31","paymentDate":"2019-06-19","value":35,"currency":"JPY"},{"executeDate":"2019-09-27","recordDate":"2019-09-30","paymentDate":"2019-12-03","value":35,"currency":"JPY"},{"executeDate":"2020-03-30","recordDate":"2020-03-31","paymentDate":"2020-06-18","value":35,"currency":"JPY"},{"executeDate":"2020-09-29","recordDate":"2020-09-30","paymentDate":"2020-12-01","value":40.5,"currency":"JPY"},{"executeDate":"2021-03-30","recordDate":"2021-03-31","paymentDate":"2021-06-16","value":13.5,"currency":"JPY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSKYF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1721188800000}}}